Pharm
Elbasvir Grazoprevir
search
Elbasvir Grazoprevir
, Elbasvir/Grazoprevir, Zepatier
See Also
Hepatitis C Antiviral Regimen
Hepatitis C
Precautions
See
Hepatitis C Antiviral Regimen
Indications
See
Hepatitis C Antiviral Regimen
Hepatitis C
Genotype
1a (alternative agent)
Hepatitis C
Genotype
1b
Hepatitis C
Genotype
4
Advantages
Priced lower than other
Genotype
I regimens
May be used despite GFR <30 ml/min
Contraindications
See
Hepatitis C Antiviral Regimen
Child Pugh Class B or C (or CTP score >=7)
Mechanism
Elbasvir is a NS5A
Protein
Inhibitor (...asvirs)
Grazoprevir is a NS3/4A
Protease Inhibitor
(...previrs)
Dosing
Take once daily for 12 weeks
Evaluation
See
Hepatitis C Antiviral Regimen
for Pre and post-treatment protocols
Efficacy
As effective as other agents used in
Genotype
1
Hepatitis C
infections
Adverse Effects
See
Hepatitis C Antiviral Regimen
Common (>5%)
Fatigue
Headache
Nausea
Serious
Liver
injury or hepatic failure
Do not use in Child Pugh Class B or C
Drug Interactions
See
Hepatitis C Antiviral Regimen
Statin
s
Atorvastatin
(avoid dose >20 mg daily)
Rosuvastatin
(avoid dose >10 mg daily)
Use lowest adequate dose of
Fluvastatin
,
Lovastatin
or
Simvastatin
Monitor for
Statin-Induced Myopathy
Avoid with strong and moderate
CYP3A Inducer
s
Bosentan
Carbamazepine
Efavirenz
Etravirine
Modafinil
Nafcillin
Phenytoin
Rifampin
St. Johns Wort
Avoid with strong
CYP3A Inhibitor
s
Cobicistat
Ketoconazole
Avoid with OATP1B1/3 Inhibitors
Atazanavir
Cyclosporine
Darunavir
Lopinavir
Saquinavir
Tipranavir
Monitoring
See
Hepatitis C Antiviral Regimen
Recheck
Liver Function Test
s at 8 weeks
If using a 16 week course, also recheck at 12 weeks
Resources
Zepatier (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=164dc02a-9180-426a-b8b5-04ab39d2bbd4
References
(2023) Presc Lett,
Hepatitis C
Treatment Overview, Resource #390902
Type your search phrase here